Sovran Advisors, LLC
Source: SEC Form 13F · as of Mar 2026Sovran Advisors, LLC holds 22 biotech & pharma companies tracked by BioSniper, totaling $22.7M in value as of Mar 2026 (SEC Form 13F).
Companies held
22
Total value held
$22.7M
| Company | Shares | Value |
|---|---|---|
| REGNREGENERON PHARMACEUTICALS, INC. | 6,019 | $4.3M |
| JNJJOHNSON & JOHNSON | 11,697 | $2.7M |
| LLYELI LILLY & Co | 2,731 | $2.6M |
| AMGNAMGEN INC | 5,910 | $2.0M |
| ABBVAbbVie Inc. | 7,078 | $1.5M |
| PMPhilip Morris International Inc | 8,096 | $1.3M |
| ABTABBOTT LABORATORIES | 11,408 | $1.0M |
| GILDGILEAD SCIENCES, INC. | 7,843 | $1.0M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,061 | $764K |
| PFEPFIZER INC | 24,346 | $650K |
| NVSNovartis AG | 4,259 | $630K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 1,392 | $595K |
| GALTGALECTIN THERAPEUTICS INC | 257,830 | $585K |
| AZNASTRAZENECA PLC | 2,827 | $530K |
| BMYBRISTOL MYERS SQUIBB CO | 8,724 | $529K |
| NVONovo Nordisk A/S | 11,487 | $485K |
| MRKMerck & Co., Inc. | 3,587 | $392K |
| MCKMcKesson Corporation | 342 | $279K |
| LNTHLantheus Holdings, Inc. | 2,780 | $235K |
| ELVElevance Health Inc. | 575 | $217K |
| CAHCardinal Health Inc. | 1,106 | $213K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,980 | $208K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.